GlassScriptPhysician profile
Bruce B Banias
NPI 1639134703
$2,825.62
in general payments reported to CMS, 2019-2025
23 companies · $97.47 in 2025
The $97.47 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,265 · 2020: $547 · 2021: $297 · 2022: $346 · 2023: $273 · 2025: $97.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $581.46 | 2019-2022 | |
| Novo Nordisk INC | $322.41 | 2019-2021 | |
| Therapeuticsmd, INC. | $289.92 | 2019-2020 | |
| Medicem INC. | $208.17 | 2021-2022 | |
| Lupin INC. | $197.65 | 2019-2020 | |
| Amgen INC. | $163.78 | 2019-2020 | |
| Gynesonics, INC. | $146.94 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Meditrina | $126.17 | 2023 | |
| Myovant Sciences INC. | $125.00 | 2022 | |
| Biogen, INC. | $97.47 | 2025 | Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $94.88 | 2019 | |
| Vertical Pharmaceuticals, LLC | $94.35 | 2019-2020 | |
| Hologic Sales and Service, LLC | $77.83 | 2019 | |
| Coopersurgical, INC. | $63.63 | 2019-2020 | |
| Pfizer INC. | $57.64 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $30.93 | 2020 | |
| Amag Pharmaceuticals, INC. | $29.09 | 2019-2020 | |
| Avion Pharmaceuticals | $28.65 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.91 | 2019 | |
| Merck Sharp & Dohme LLC | $24.63 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $13.90 | 2019 | |
| Currax Pharmaceuticals LLC | $13.36 | 2020 | |
| Daiichi Sankyo INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Banias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.